![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Cilag Ag Schaffhausen Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Remifentanil hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2018-296 - Rev 01
This Chemical Type CEP, issued on March 22, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2644 associated with this CEP further emphasizes